✦ LIBER ✦

The interferon sensitivity determining region in the era of combination therapies and the rational use of such therapies for patients with HCV genotype 1b infection

✍ Scribed by Hisashi Moriguchi; Raymond T Chung; Ana Maria Contreras; Namiki Izumi; Takamoto Uemura; Makoto Kobayashi; Chifumi Sato

Book ID: 119241034
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 75 KB
Volume: 125
Category: Article
ISSN: 0016-5085
DOI: 10.1016/j.gastro.2003.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-276 Serum HCV-RNA level and the mutati

P-276 Serum HCV-RNA level and the mutation in the interferon sensitivity determining region of chronic hepatitis C patients with genotype 1B infection

✍ T Murakami; N Enomoto; I Sakuma; N Izumi; F Marumo; C Sato 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

1089 COMBINATION OF FLUVASTATIN WITH PEG

1089 COMBINATION OF FLUVASTATIN WITH PEGYLATED INTERFERON/RIBAVIRIN THERAPY REDUCES THE VIRAL RELAPSE RATE IN CHRONIC HEPATITIS C INFECTED WITH HCV GENOTYPE1B

✍ Atsukawa, M.; Tsubota, A.; Kondo, C.; Itokawa, N.; Hashimoto, S.; Fukuda, T.; Ma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

153 THE DYNAMIC ANALYSIS OF THE TH1/TH2

153 THE DYNAMIC ANALYSIS OF THE TH1/TH2 RATIO DURING THE INTERFERON ALPHA/RIBAVIRIN COMBINATION THERAPY FOR HCV GENOTYPE 6 INFECTED PATIENTS

✍ X. Shao; Z. Zhao; Q. Cai; X. Zhang; Z. Gao 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

P.233 Modified combination therapy with

P.233 Modified combination therapy with interferon and ribavirin in the treatment of elderly patients infected with genotype 1b and high viral loads

✍ H. Kohno; M. Kitamoto; Y. Aisaka; H. Kawakami; S. Aimitsu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB